One Tool to Rule Them All: CRISPR and Emerging Biotechnologies
May 10, 7:00 pm - 8:00 pm
New gene editing technologies like CRISPR have enabled exciting advances in science and health and led to a wealth of related emerging biotechnologies, from gene drives to the next generation of chimeric animal models. But some applications of CRISPR are raising ethical and other concerns, and are presenting interesting policy challenges to our current oversight system for research in the life sciences. What can we learn from previous experiences with emerging biotechnologies and how can we adapt our current policy framework to the gene editing technologies of today and tomorrow?
Dr. Carrie Wolinetz is Associate Director for Science Policy and Director of the Office of Science Policy (OSP) at the National Institutes of Health (NIH). As leader of OSP, she advises the NIH Director on science policy matters of significance to the agency, the research community, and the public, on a wide range of issues including human subjects protections, biosecurity, biosafety, genomic data sharing, regenerative medicine, the organization and management of NIH, and the outputs and values of NIH-funded research. She has a BS in animal science from Cornell University and a PhD in animal science from The Pennsylvania State University, where her area of research was reproductive physiology.
The lecture is free and open to the public; however, e-tickets are required.
Parking is free in Library parking lots and along the west side of Holmes Street between 51st and 52nd streets. The main entrance to the Library grounds is on Cherry Street. The Linda Hall Library is not affiliated with UMKC. Parking in all UMKC lots is by permit or meter. Doors open at 6:00 p.m.
Questions? Contact Eric Ward at 816.926.8753 for more information about these events.